TG Therapeutics Inc (TGTX)
16.60
-0.32
(-1.86%)
USD |
NASDAQ |
May 10, 16:00
16.60
0.00 (0.00%)
After-Hours: 19:56
TG Therapeutics Cash from Operations (TTM): 20.28M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.28M |
| December 31, 2023 | -31.41M |
| September 30, 2023 | -42.07M |
| June 30, 2023 | -160.27M |
| March 31, 2023 | -167.38M |
| December 31, 2022 | -176.17M |
| September 30, 2022 | -239.21M |
| June 30, 2022 | -271.92M |
| March 31, 2022 | -282.97M |
| December 31, 2021 | -295.63M |
| September 30, 2021 | -260.75M |
| June 30, 2021 | -250.08M |
| March 31, 2021 | -233.75M |
| December 31, 2020 | -214.51M |
| September 30, 2020 | -192.87M |
| June 30, 2020 | -169.54M |
| March 31, 2020 | -161.57M |
| December 31, 2019 | -132.81M |
| September 30, 2019 | -136.10M |
| June 30, 2019 | -135.91M |
| March 31, 2019 | -134.23M |
| December 31, 2018 | -128.92M |
| September 30, 2018 | -117.09M |
| June 30, 2018 | -106.86M |
| March 31, 2018 | -99.50M |
| Date | Value |
|---|---|
| December 31, 2017 | -93.76M |
| September 30, 2017 | -88.93M |
| June 30, 2017 | -81.19M |
| March 31, 2017 | -67.21M |
| December 31, 2016 | -61.59M |
| September 30, 2016 | -57.47M |
| June 30, 2016 | -53.08M |
| March 31, 2016 | -52.48M |
| December 31, 2015 | -44.69M |
| September 30, 2015 | -46.90M |
| June 30, 2015 | -44.29M |
| March 31, 2015 | -35.61M |
| December 31, 2014 | -35.06M |
| September 30, 2014 | -24.78M |
| June 30, 2014 | -17.88M |
| March 31, 2014 | -16.86M |
| December 31, 2013 | -10.74M |
| September 30, 2013 | -6.748M |
| June 30, 2013 | -8.588M |
| March 31, 2013 | -6.531M |
| December 31, 2012 | -5.188M |
| September 30, 2012 | -4.411M |
| June 30, 2012 | -1.448M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.0866M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-295.63M
Minimum
Dec 2021
20.28M
Maximum
Mar 2024
-176.73M
Average
-172.86M
Median
Cash from Operations (TTM) Benchmarks
| Amicus Therapeutics Inc | -69.09M |
| Geron Corp | -183.63M |
| Editas Medicine Inc | -146.28M |
| G1 Therapeutics Inc | -18.18M |
| Mersana Therapeutics Inc | -168.88M |